U.S. Transportation Stock News

AI has pulled huge amounts of capital into a small group of tech giants, but the recent US$2.3t drop in the “Magnificent Seven” shows how quickly sentiment can shift when investors question the payoff from heavy AI spending. At the same time, suppliers like Micron, Intel, Marvell, AMD, and Sandisk are attracting attention as key links in the AI infrastructure chain, supported by tight supply and strong demand. This article looks at three technology value stocks exposed to this news theme to...

In late June 2026, Accor announced a new phase of its long-term alliance with H World Group, rolling out a phased partnership through 2026 to link their direct booking platforms and loyalty benefits across China, Europe and the Middle East. This tie-up connects Accor’s nearly 120 million ALL Accor members with H World’s more than 310 million H Rewards members, creating a combined ecosystem of about 430 million loyalty customers and close to two million rooms while keeping each program...

SharonAI Holdings (SHAZ) has closed an oversubscribed US$1.6 billion private placement, funding a six year collaboration with NVIDIA and a planned build out of large scale AI infrastructure and GPU capacity. See our latest analysis for SharonAI Holdings. The latest US$1.6b raise and index inclusions have arrived during a period of sharp momentum for SharonAI Holdings, with a 30 day share price return of 11.64% and a 90 day share price return above 200%. This contrasts with a 3 year total...

In late June 2026, Griffon Corporation (NYSE:GFF) was added to several Russell value-oriented indices, including the Russell 2000 Value, Russell Small Cap Comp Value, Russell 2500 Value, Russell 3000 Value, Russell 3000E Value, and the Russell 2000 Value-Defensive Index. This broad inclusion across value-focused benchmarks embeds Griffon more deeply into quant and passive portfolios, potentially altering how investors view its profile within the home and building products space. We’ll now...

Anthropic’s launch of Claude Science has thrown fresh attention on stocks that sit at the intersection of artificial intelligence and drug discovery, where software meets lab science. For investors watching this theme, the question is which companies might gain most from large pharma and biotech groups exploring AI tools for protein modelling, target identification and faster experiments, and which might struggle if regulation tightens. This article picks out 3 stocks from our AI Powered Drug...

Roadzen (NasdaqGM:RDZN) has just posted its FY 2026 fourth-quarter numbers, reporting revenue of about US$16.1 million and a basic EPS loss of US$0.09. Trailing twelve-month revenue came in at roughly US$55.0 million and EPS at a loss of US$0.29. Over recent periods the company has seen quarterly revenue move from US$11.4 million in Q4 FY 2025 to US$16.1 million in Q4 FY 2026. Over the same timeframe, basic EPS shifted from a small loss of US$0.00 to a wider loss of US$0.09. This leaves...

FedEx (NYSE:FDX) has completed the spin-off of its FedEx Freight unit. FedEx Freight is now a separate, publicly traded company with its own business strategy. The newly independent FedEx Freight has released its first stand-alone financial and strategic updates. For FedEx, this move reshapes how its core operations are organized across express, ground and less than truckload freight services. Investors now see FedEx Freight as a focused trucking business, while the remaining FedEx...

U.S. federal appellate court rules that Ardelyx’s Xphozah will be included in Medicare’s ESRD bundled payment system, ending separate reimbursement. The decision resolves a long-running legal dispute over how the drug is treated under Medicare’s payment structure for dialysis care. The ruling affects how dialysis providers are paid for Xphozah and may influence pricing decisions and product positioning for NasdaqGM:ARDX. Ardelyx, the biopharmaceutical company behind Xphozah, focuses on...

AI infrastructure has shifted from a niche theme to a major force in markets, as investors respond to headlines about Micron, Intel, AMD and other chip stocks adding trillions in combined market value. Instead of chasing every hype cycle, it can help to focus on companies with solid financial and market metrics that are directly exposed to this AI infrastructure build out. This article walks through 3 stocks from our AI Infrastructure Beneficiaries screener that appear positively exposed to...

In late June 2026, Olema Pharmaceuticals, Inc. (NasdaqGS:OLMA) was added to multiple Russell Growth Benchmarks, including the Russell 2000, 2500, 3000, 3000E, Small Cap Comp, and Microcap Growth indices. This broad index inclusion brings Olema onto the radar of a wide range of index-tracking funds and quantitative investors, potentially changing how the company is positioned in many portfolios. Next, we will examine how Olema’s broad Russell Growth index inclusion shapes its investment...

With UK GDP slipping 0.1% in April and inflation risks back in focus, many investors are rethinking how much economic stress their portfolios can handle. Consumer staples stocks, which sell everyday essentials, can sometimes offer a steadier ride when growth cools and headlines turn harsher. This article looks at how the latest UK data, conflict in Iran and Bank of England inflation warnings could affect large, defensive companies in this space. Ahead, you will see 3 stocks from our Consumer...

In the past week, Concentrix Corporation reported second-quarter 2026 results showing revenue of US$2,462.47 million and net income of US$55.28 million, alongside updated guidance that points to minimal constant-currency revenue growth for the third quarter and full fiscal year. Despite meeting revenue expectations and achieving record iX Suite contract signings with very large year-on-year growth, Concentrix reduced its full-year outlook while affirming its dividend and completing a...

Why Vor Biopharma’s index additions matter for investors Vor Biopharma (VOR) has just been added to a wide range of Russell indexes, including the Russell 2000 and Russell 3000 families, drawing fresh attention from investors and index tracking funds. This kind of broad index inclusion often prompts passive institutional buying activity, which can influence liquidity and trading volumes in the stock. For you as an investor, the key questions are how meaningful this index presence might be and...

With Janet Yellen urging more disciplined fiscal policy, the Federal Reserve hinting at a pause in rate hikes, and inflation data easing some of the pressure on monetary policy, growth stocks are back in focus for investors weighing risk and reward. The current mix of cautious optimism and uncertainty can reward companies that already have solid revenue trends and sensible reinvestment plans. This article looks at three growth stocks from our screener that appear closely tied to these policy...

Spire Inc. recently reported strong adjusted earnings and raised its full-year guidance, citing continued benefits from its natural gas infrastructure investments. This combination of improved results and a higher earnings outlook underscores the resilience of Spire’s regulated utility model and cash-flow profile. Next, we’ll examine how Spire’s upgraded full-year guidance feeds into its existing investment narrative around regulated expansion and earnings stability. Explore 26 top quantum...

From what we can see, insiders were net sellers in Innventure, Inc.'s ( NASDAQ:INV ) during the past 12 months. That...

Rocket Lab has announced an agreement to acquire satellite communications company Iridium, creating a new vertically integrated player in the sector. The deal brings together launch services and Iridium's established low Earth orbit network, reshaping the competitive field that includes Viasat (NasdaqGS:VSAT). This transaction has not been widely discussed in relation to Viasat, even though it could influence how investors think about different satellite business models. Viasat, traded as...

Federal student loan rules are shifting again, and this time the changes reach deep into graduate and professional programs. Higher annual borrowing caps and a wider range of eligible degrees could alter how money flows into universities, education services and student lending businesses. That creates fresh angles for both opportunity and risk as funding access reshapes demand. This article looks at 3 stocks from our Higher Education and Student Lending Stocks screener that appear especially...

Webull (BULL) has caught investor attention after recent trading, with the stock closing at $6.75 and short term returns mixed, up about 5% over the past month but down year to date. See our latest analysis for Webull. While Webull’s share price return over the past 90 days is up 40.62%, the year to date share price return is down 17.58% and the 1 year total shareholder return is down 43.56%. This suggests that recent momentum contrasts with weaker longer term performance. If you are weighing...

WisdomTree (NYSE:WT) has expanded its international ETF lineup with a new Asia Defense fund that excludes China. The fund targets companies tied to defense spending and related themes in Japan, South Korea, and India. The expansion also highlights a focus on tactical themes such as semiconductors and regional security supply chains. For investors watching ETF providers move beyond U.S. mega-caps, WisdomTree is leaning into global and sector-focused products. The new Asia Defense fund sits...

If you are wondering whether Casey's General Stores stock still offers value after a strong run, you are not alone in asking what a fair price looks like today. The share price recently closed at US$780.24, with returns of 40.3% year to date and 53.4% over the past year, even after a 6.2% decline in the last week and a modest 1.7% gain over the past month. Recent news coverage has focused on Casey's General Stores as investors look for context behind this very large 3 year return of 225.6%...

On 27 June 2026, Globalstar, Inc. was dropped from the Russell 2000 family of indices and simultaneously added to the Russell 1000, Russell Midcap, and related growth and dynamic benchmarks, marking a shift in its classification within the Russell index universe. This reclassification alters how many index-tracking and quantitative funds may hold Globalstar, potentially reshaping its shareholder base and trading patterns over time. Next, we will examine how Globalstar’s move into larger-cap...

The market remained flat over the last week, but over the past 12 months, it has risen by 20%, with earnings expected to grow by 19% per annum in the coming years. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive market trends.

If you are wondering whether EMCOR Group at around US$814 a share is still offering good value or has run too far ahead, this article walks through the numbers in a clear, practical way. The stock has had a mixed short term pattern, with the share price down 6.3% over the past week and down 1.5% over the past month, while still showing a 27.5% gain year to date and a 52.5% return over the last year. Recent coverage has focused on EMCOR Group's position within the construction and capital...